Company Overview and News


Add AB
to your dashboard

Headline News

3 Things In Biotech You Should Learn Today: September 17, 2017

2017-09-17 seekingalpha
Welcome to another edition of "3 Things In Biotech You Should Learn Today," a daily digest dedicated to helping you keep pace with the fast-moving world of pharmaceutical and biotechnology research. (4-0)

Prostate Cancer Pipeline H1 2017 Therapeutic Key Players 3-V Biosciences Inc, 4SC AG, Actinium Pharmaceuticals Inc and Advaxis Inc, Says a New Research Report at RnRMarketResearch.com

2017-07-11 prnewswire
Prostate Cancer Pipeline Review, H1 2017 is new research report highlights details analysis includes 1845 pages with latest updates, Drug Profiles, Key players, Table of Contents, List of Tables, List of Figures. (0-2)

French Regulators Order AB Science to Temporarily Suspend Work on Phase III ALS Trial

2017-05-12 biospace
AB Science announces that ANSM requested the temporary suspension of clinical studies conducted in France following deviations from Good Clinical Practice (GCP) standards

Mitsubishi Bags ALS Approval Without Radical Benefit

2017-05-09 seekingalpha
Amyotrophic lateral sclerosis (ALS) patients will no doubt be relieved to have a new option after the FDA approved Mitsubishi Tanabe Pharma's edaravone, known in the US as Radicava. But with a $145,000-per-year price tag and no proof yet that it improves survival, getting it paid for might be a different matter.

Pipeline of Depression Market Covering Therapeutics Under Development for H2 2016

2016-10-24 prnewswire
RnRMarketResearch.com adds "Depression - Pipeline Review, H2 2016" to its store. The report provides an overview of the Depression's therapeutic pipeline with comprehensive information on the therapeutic development for Depression, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases.

Collaborative Leukemia Trial Orbits Moonshot Initiative

2016-10-20 seekingalpha
The once-neglected blood cancer acute myeloid leukemia has seen a flurry of activity of late – which might explain why four companies with mid-stage projects are taking the unusual step of getting involved in a collaborative study.

Alzheimer's Disease: Market Opportunity And Major Phase 3 Treatments To Know About

2016-10-14 seekingalpha
Lilly’s (LLY) hotly anticipated Phase III data for Alzheimer’s Disease drug solanezumab has left many investors with questions about LLY and AD treatment in general.

NewLink's Pancreatic Cancer Candidate Fails To Impress

2016-09-20 seekingalpha
The phase III failure of NewLink Genetics' (NASDAQ:NLNK) algenpantucel-L is not only a blow to the company, it also dashes hopes of getting a new pancreatic cancer therapy approved any time soon. Of the four pivotal trials in the disease that were due to read out this year, three have already fizzled out (see tables below).

MediciNova: CEO Faces Undisclosed Illegal Kickback Lawsuit, Failed Science, Perplexing Related Party Transactions, -84% Downside

2016-09-19 seekingalpha
Perplexing illegal kickback lawsuit creates the possibility of government funding loss and cash clawback at MNOV; stock could go to zero.

Colorectal Cancer Pipeline 2016 Global Market Review Covering 227 Companies

2016-08-10 prnewswire
RnRMarketResearch.com adds "Colorectal Cancer - Pipeline Review, H1 2016" market research report to its store providing an overview and comprehensive information on the therapeutic development for Colorectal Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases.

Pancreatic Cancer Pipeline 2016 Market Report of 282 Companies

2016-08-02 prnewswire
ReportnReports.com adds "Pancreatic Cancer - Pipeline Review, H1 2016" market research report providing comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Pancreatic Cancer and special features on late-stage and discontinued projects.

Pipeline of Asthma Market Covering 129 Companies Reviewed for H1 2016 in New Research Report

2016-05-31 prnewswire
RnRMarketResearch.com adds "Asthma - Pipeline Review, H1 2016" market research report with comparative analysis of Asthma therapy at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Asthma and special features on late-stage and discontinued projects.

AB Science Claims A Positive Result In Masitinib ALS Study

2016-04-19 seekingalpha
France’s AB Science (OTCPK:ABSCF) seems to have notched up an unexpected positive interim readout in a phase III study with its c-KIT inhibitor, masitinib, in the difficult indication of amyotrophic lateral sclerosis (ALS). The result could represent the first progress in the ALS field in more than two decades.

Depression Pipeline Market H2 2015 Review (87 Companies) Report

2016-03-14 prnewswire
RnRMarketResearch.com adds "Depression - Pipeline Review, H2 2015" market research report to its store with comprehensive information on the therapeutic development for Depression, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases.

Metastatic Melanoma Pipeline H2 2015 Report on Drugs and Companies

2016-01-29 prnewswire
PUNE, India, January 29, 2016 /PRNewswire/ -- ReportsnReports.com adds